Brief: Glaxosmithkline Pharmaceuticals Sept-Quarter Profit At 2.53 Bln Rupees
29/10/2024 11:12
Oct 29 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd
GLAX.NS :
* SEPT-QUARTER PROFIT 2.53 BILLION RUPEES
* SEPT-QUARTER REVENUE FROM OPERATIONS 10.11 BILLION RUPEES
* NUMBERS ARE IN CONSOLIDATED BASIS
* DIVIDEND 12 RUPEES PER SHARE
Source text: ID:nBSE4pH2MH
Further company coverage: GLAX.NS
((Reutersbriefs@thomsonreuters.com;))
Recent news on GlaxoSmithKline Pharmaceuticals
See all newsGSK India first-quarter profit rises on steady vaccine demand
Brief: Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority
India's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees